Effects of a health program comprising reassurance and patient education, diet management, administration of probiotics and regular exercise on symptoms and quality of life in patients with IBS were investigated.
Introduction
Irritable bowel syndrome (IBS) is a chronic condition that is characterized by abdominal discomfort or pain, altered bowel habits, and often bloating and abdominal distension. The degree of symptoms varies in different patients from tolerable to severe, interfering with daily activity. 1 Estimates of prevalence of IBS varies from 12-30% but using recent diagnostic criteria it appears to affect 5-10% of individuals worldwide. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] IBS is more common in women than in men and more commonly diagnosed in patients under the age of 50 years. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] IBS reduces quality of life to the same degree of impairment as major chronic diseases such as congestive heart failure, hepatic cirrhosis, renal insufficiency and diabetes. [15] [16] [17] [18] In an international survey, 19 patients with IBS have reported impaired health status, restriction of daily activities for an average 73 days in a year, having poor health-related quality of life, particularly with regard to dietary restrictions, mood disturbance, and interference with daily activity. Furthermore, this survey showed that these patients would give up 25% of their remaining life (average 15 years) and 14% would risk a 1/1000 chance of death to receive a treatment that would make them symptom free.
Although a minority (10-50%) of IBS patients seek healthcare, they generate a substantial workload in both primary and secondary care. [6] [7] [8] It is estimated that 12-14% of primary care patient visits, and 28% of referrals to gastroenterologists are IBS patients, making this a more common reason for a visit to a physician than diabetes, hypertension or asthma. [20] [21] [22] Not only do IBS patients visit doctors more frequently, but they also undergo more diagnostic tests, consume more medications, miss more days at work, have lower work productivity, are hospitalized more frequently, and consume more overall direct costs than those without IBS. 14 The annual costs in the USA (both direct and indirect) to manage patients with IBS are estimated at 15-30 billion US dollars. 6, 23, 24 Conventional therapy for IBS has focused on systematic relief of symptoms such as pain, diarrhea and constipation. Evidence of the long-term benefit of pharmacological agents has been sparse and new agents which proved to be affective have raised issues concerning safety. 25, 26 Not surprisingly, other alternative therapies have been considered. Thus, cognitive behavior therapy and gut-directed hypnotherapy have been used with good results. 27 Other non-pharmacological approaches have also been tried with proved effect on symptoms and quality of life in patients with IBS. 27 Providing reassurance and information to patients with IBS, 28, 29 diet management, 30, 31 administration of probiotics, and regular exercise have each been found to reduce symptoms and improve quality of life. [32] [33] [34] Against this background, the present study was undertaken to establish the effects of a health program comprising reassurance and patient information, diet management, administration of probiotics and regular exercise on symptoms and quality of life in patients with IBS.
Materials and Methods

Patients
Patients were recruited from those who were referred to the gastroenterology section, Stord Helse-Fonna Hospital from January 2006 to February 2008. Patients between 18 and 60 years of age who satisfied Rome III criteria for the diagnosis of IBS were considered for inclusion in the study. 35 Those with organic gastrointestinal disease, clinically significant systemic diseases, and pregnant or lactating women were excluded. Patients who had undergone any abdominal surgery, with the exception of appendectomy, caesarean and hysterectomy, were also excluded. The study was performed in accordance with the Declaration of Helsinki and was approved by the local Committee for Medical Research Ethics. All patients gave oral and written consent.
Study design
The patients went through a program combining reassurance and IBS education, guidance in diet management, intake of probiotics and regular exercise. The patients were asked to complete the Birmingham IBS symptom score questionnaire, the SF-36 questionnaire and the IBS-quality of life (IBS-QOL) questionnaire before starting the program and three, six, 12 and 24 months after completing the program. The patients were allowed to use dimeticon (200 mg) tablets on demand. The program was carried out by a clinical team with special interests in IBS. This team consists of a senior gastroenterologist and 3 registered nurses.
Reassurance and irritable bowel syndrome patient education Eligible patients had 2 one hour sessions with a gastroenterologist taken on 2 different occasions about a month apart. In the first session of about 60 min, a full clinical history was taken and a thorough explanation was given of IBS diagnosis, the underlying mechanism of the disease, prognosis, and pharmacological and non-pharmacological treatment possibilities, with an emphasis on the treatment included in the program. This information was given in oral and written form. In the second session, a 15 min summary of the same information was given. Moreover, in this session a complete physical examination was performed and blood tests were taken to exclude liver, pancreas, kidney, endocrine or blood diseases. Gastroscopy with duodenal biopsies to exclude celiac disease and colonoscopy with biopsies to exclude microscopic colitis were performed on separate occasions.
Guidance on diet management
The patients were asked to keep a diet diary for at least a month. In this diary they wrote the time and kind of food and drinks they ingested daily. They also noted occurrence of pain, abdominal distension, as well as stool frequency and consistency. Symptoms were graded as light, moderate or severe. Two sessions with a registered nurse were scheduled of about an hour each. In the first session, the information given earlier by the gastroenterologist was repeated in a 20 min summary, emphasizing the role of diet. This information was given orally using charts and illustrative drawings. In the remaining 40 min, the nurse examined the diet diary together with the patient. Diet instructions focused on the fibre content of the diet (soluble and non-soluble), identification of any food intolerances, regular meals and healthy eating habits. Together with the patient, the nurse outlined a diet that was suitable for the patient to try in the following month. A new diet diary was kept by the patient for the next session which was conducted in the same way as the first.
Probiotics intake
The patients were asked to take a course of the commercially available probiotics, Idoform balance ® , at least twice a year. Each course lasted two months. Two patients reported a relapse of the IBS symptoms when they stopped ingesting probiotics. These patients took probiotics continually under the study.
Regular exercise
The patients were advised to exercise regularly at least 3 times a week. Exercise instruction emphasized involvement in aerobic activity, such as walking.
Probiotic preparation
The commercially available probiotic preparation, Idoform balance ® from Ferrosan Norge AS was used. This probiotic preparation is in tablet form and contains 10 9 colony-forming units (CFU) LGG Lactobacillus rhamnosus GG® and 10 9 CFU Bifdobacterium, BB-12
Irritable bowel syndrome symptom assessment
The Birmingham IBS symptom score questionnaire was used in assessment of patients with IBS. This questionnaire has been developed to be suitable for self-completion and has been found to be acceptable to patients, and its dimensions have good reliability, external validity and sensitivity. 36 The Birmingham IBS symptom score comprises questions based on the frequency of IBS symptoms. Each question had a standard response scale with symptoms all being measured on a 6-point Likert scale ranging from 0 = "none of the time" to 5 = "all of the time". This questionnaire has 3 underlying dimensions: pain (3 items), diarrhea (5 items) and constipation (3 items).
Assessment of quality of life
The quality of life in patients with IBS was assessed by the SF-36 questionnaire and the IBS-quality of life (IBS-QOL) questionnaire.
The SF-36 is a 36-item questionnaire that consists of 8 health concepts. Each concept is made up of a number of distinct questionnaire items. The 8 health concepts are: physical functioning (10 items), role limitations-physical (4 items), body pain (2 items), general health (5 items), vitality (4 items), social functioning (2 items), role limitations-emotional (3 items), mental health (5 items) and reported health transition (1 item). 37 Each of the concepts is reported as a score from 0 (worst possible) to 100 (best possible). The SF-36 questionnaire has been applied widely to clinical trials. Analyses of the physical and mental health scales of the SF-36 have demonstrated that they are capable of discriminating between healthy subjects and patients with moderate levels of psychiatric or physical illness.
38-41 SF-36 has been found to be not only sensitive to the presence of IBS, but also provides a useful tool for evaluating treatment outcomes for IBS. 37 The IBS-quality of life (IBS-QoL) questionnaire is a 34-item disease-specific quality-oflife document concerning physical and psychosocial functioning as a result of IBS. 42 This questionnaire consists of 8 domains: dysphoria, interference with activity, body image, health worry, food avoidance, social reaction, sexual function, and impact on relations.
Statistical analysis
The Kruskal-Wallis non-parametric ANOVA test and Dunn's post-test were used. P-values <0.05 were considered significant.
Results
Patients
A total of 180 patients were enrolled in the study. Of these patients, 11 were excluded because of celiac disease (6), microscopic colitis (2), Chron's disease (2) and colon carcinoma (1). Twenty-six patients dropped out. Of these 26, 18 were females (mean age 30 years; range 18-40 years) and 8 were males (mean age 31 years; range 18-37 years). Thus, 143 patients satisfactorily completed the study: 95% were women and 5% were men. Patients were an average 32 years of age (range 18-58 years). Ninety-six of these patients had diarrhea as the predominant symptom and 47 had constipation as the predominant symptom.
Diet and exercise
Examining the diet diary showed that patients with IBS in general did not tolerate gas-forming food such as beans, onions, celery, carrots, raisins and bananas. However, some tolerate a small amount of this food. Moreover, patients did not tolerate in various degrees wheat or wheat products. Under this program, some patients reported improvement of IBS symptoms with reduced consumption of fat, protein or carbohydrates. Others reported the opposite. All patients exercised at least 40 min 3 times a week. 
IBS symptoms
The total score of symptoms as assessed by the Birmingham IBS symptom questionnaire was decreased significantly three, six, 12 and 24 months after completing the program (Figure 1 ). All the 3 dimensions (pain, diarrhea and constipation) were diminished significantly after completing the program at all observation times.
Quality of life
The total score of quality of life as assessed by the SF-36 questionnaire was significantly improved in patients with IBS at all observation times after completing the program (Figure 2 ). It seems that the quality of life in patients with constipation as a predominant symptom has been improved more than those with diarrhea as a predominant symptom, but this difference was not statistically significant. Neither was there any difference between the 2 subtypes of IBS regarding all the SF-36 health concepts. There was a statistically significant improvement in all health concepts except in both physical and mental role limitation ( Table 1) .
The total score of quality of life as measured by the IBS-QoL questionnaire was significantly improved in patients with IBS three, six, 12 and 24 months after completing the program (Figure 3) .
There was no statistical difference between patients with IBS with diarrhea-and constipation-predominant symptoms. All the domains were significantly improved except food avoidance and sexual relations ( Table 2 ). There was no statistical difference between patients with diarrhea-or constipation-predominant symptoms as regards all domains.
Discussion
In the present study, a health program combining 4 different non-pharmacological approaches was used. Each of them showed improvement in the symptoms and quality of life of patients with IBS. These approaches are reassurance and patient education, diet management, probiotics administration and regular exercise. The program required relatively low resources, namely two hours consultation with a physician and two hours consultation with a nurse, as well as a gastroscopy and colonoscopy. The present findings clearly show an improvement in symptoms and in the quality of life in patients with IBS who took part in this program. It is noteworthy, however, that the ratio of females to males was 19:1, which is much higher than the IBS gender ratio in the general population. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] One should be cautious, therefore, when applying the results and conclusions drawn here on male IBS patients.
An effective physician-patient relationship giving reassurance and providing a thorough explanation of the IBS disorder has been found to reduce the use of health care and diminishes the fear of cancer. [43] [44] [45] A fifteen minute thorough oral explanation of the diagnosis and the underlying mechanism of IBS, and a complete physical examination by a gastroenterologist during the first consultation, reduced the selfperception of impairment in daily function. 28 Furthermore, a structured 3-hour IBS educational class for patients with IBS has been reported to improve symptoms and some health-promoting behaviors. 29 In the present program, a two hour thorough explanation with information about IBS was given by a gastroenterologist and a nurse. Moreover, in order to reassure the patients, a complete physical examination, blood tests, gastroscopy with biopsies and colonoscopy with biopsies were performed. The information given to the IBS patients in the present program fulfilled the 5 principles of effective patient education: i) relevant to the patient's need and abilities; ii) individualization; iii) feedback; iv) reinforcement; v) promoting a change in behavior. 46, 47 Most patients with IBS believe diet plays a significant role in their symptoms and 63% were interested in knowing what food to avoid. 30 It has been shown that the IBS patients have non-specific diet intolerance. 48 This lack of specificity causes considerable difficulty for IBS patients in choosing their diets. 48 There is a marked difference in opinions about the role of diet in IBS symptoms. 30 The present study has not been designed or aimed at studying the diet IBS patients tolerate, but at studying the effect of diet management. This study showed, however, that patients with IBS did not tolerate gas-forming food which is in accordance with other earlier observations. 30 Moreover, patients did not tolerate wheat or wheat products, probably, as pointed out previously, due to the fructan level in wheat. 30 Consumption of fat, protein and carbohydrates have been considered in association with IBS symptoms. 30, 49 Under this program, some patients reported improvement of IBS symptoms with reduced consumption of fat, protein or carbohydrates. Others reported the opposite. During the program, a considerable difference was found in food tolerability between patients and advice on diet management should, therefore, be given on an individual basis. There was no difference in food avoidance in patients with IBS before and after the program as revealed by the IBS-QOL questionnaire. This is not unexpected, as during the program food intolerance was identified and the patients were advised to avoid certain food. There is a difference, however, between food avoidance before and after the program: before the program, the patients avoided food and eating in general. After the program, they could adopt normal eating habits and avoid only some ingredients in the meals instead.
Probiotics alter colonic fermentation and stabilize colon microbiota, and several studies have shown an improvement in flatulence and abdominal distension with a reduction in composite IBS symptom score. 32, 33 Probiotics seem to enhance gut barrier function, inhibit pathogen binding and modulate gut inflammatory response. 32, 33 In the present program, a probiotic preparation containing Lactobacillus rhamnosus and Bifdobacterium was used. This choice was based on the fact that patients with IBS have fewer Lactobacillus spp. and Bifdobacterium spp. in their intestinal flora. 33, 50 Moreover, these bacteria have shown to bind to epithelial cells and inhibit pathogen binding, and to enhance barrier function. 33 Furthermore, these bacteria spp. do not produce gas on fermenting carbohydrates, an effect which would be amplified as they also inhibit the Clostridia spp. 33 It is worthy of note that 2 patients observed a relapse of the IBS symptom as soon as they stopped taking the probiotic preparation. This observation made by the patients is in agreement with the finding that one week after stopping probiotic intake they vanished from feces. Although regular exercise has been found to reduce symptoms in patients with IBS, the physiological mechanisms still need to be explored. 34 Placebo response rates are high in IBS, which make it difficult to detect the gain for therapeutic trials. [51] [52] [53] [54] Placebo response rate in IBS patients has been found to be 40.2%. 55 In contrast to that reported in ulcerative colitis patients, a lower placebo response correspond- ed with an increasing number of visits to the surgery. 55, 56 These findings are counterintuitive as clinical experience shows that a strong patient-doctor relationship improves clinical outcome. Re-examination of this finding, however, has proven its accuracy. 55 All placebo effects eventually wear of but they can last for a long time; up to two and half years for rheumatoid arthritis. 57 To what extent the improved symptoms and quality of life seen in this study are due to placebo effect is hard to say. Assuming that the positive effects of the present program is due mainly to placebo effect, one cannot afford to dispense with a treatment that works, even if we are not certain how this happens. 58 
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